SLDB: Solid Bio Long-Term Debt Volume

Symbol and logo of brand Solid Biosciences Inc (SLDB)

The financial price action for Solid Biosciences Inc. (SLDB) illustrates the dynamics of a company developing gene therapies to combat rare muscle pathologies within a niche characterized by zero competition. The project relies on a team of top geneticists provided with high compensation and scientific resources. The current metric stands at 0.02, while business success is tied to SGT-003 trials and FDA regulatory approval.

SLDB (solidbio.com) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

SLDB (Solid Bio): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price solidbio.com|SLDB - Price Target Chart
- market capitalization data:
Market Capitalization Solid Biosciences|SLDB - Total Company Value
- book capitalization data:
Net Asset Value per Share Solid Biosciences|SLDB - Company Book Value|Market Value to Book Value Ratio solidbio.com|SLDB - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Solid Biosciences Inc.|SLDB - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Solid Corp|SLDB - Company Total Debt|Debt to Net Assets Ratio Solid Biosciences|SLDB - Company Long-Term Debts|Company Short-Term Debt Solid Biosciences
Comprehensive company analysis:SLDB (solidbio.com)
Original product of solidbio.com

Professional asset selection begins with an analysis of debt load to assess capital stability. Long-term debt, amounting to 0.02, measures obligations with maturities exceeding one year, determining the business's financial leverage. For Solid Biosciences Inc. (SLDB), this resource is critical when financing costly R&D and clinical trials for Duchenne therapy. The dynamics of the firm's long-term borrowed funds provide insight into the balance between investment risk and liquidity.

Competitors of Solid Biosciences Inc. (SLDB)

Tempus Labs - Company Long-Term Debts|Company Long-Term Debt QGEN (Qiagen)|IONS: Long-Term Debt Volume|Company Long-Term Debt RGEN|RNA (Avidity Corp) - Long-Term Debt|Company Long-Term Debt CRISPR Therapeutics AG|Company Long-Term Debt genedx.com|RARE (Ultragenyx) - Company Long-Term Debts|Long-Term Debt Volume Beam Therapeutics Inc (BEAM)|SRPT - Company Long-Term Debts|TWST - Company Long-Term Indebtedness|Company Long-Term Liabilities 10x Genomics, Inc. (TXG)|NTLA - Company Long-Term Loans and Borrowings|Stoke Therapeutics, Inc. (STOK) - Company Long-Term Debts|BioLife Solutions Inc (BLFS) - Company Long-Term Debt|WVE: Company Long-Term Debts|Long-Term Debt Volume MAZE|Sionna Therapeutics Inc - Company Long-Term Debt|Long-Term Debt PRME (primemedicine.com)|Company Long-Term Debt TSHA|Long-Term Debt Volume uniQure NV QURE|MGTX: Company Long-Term Debts|RGNX - Company Long-Term Liabilities|Ocugen, Inc. - Company Long-Term Debts|pacb.com (PACB) - Long-Term Debt Volume|Company Long-Term Debts BNTC (Benitec Biopharma)|Long-Term Debt DSGN|Company Long-Term Debt Rocket Pharmaceuticals Inc RCKT|Company Long-Term Indebtedness 4D Molecular Corp (FDMT)|Lexeo Therapeutics, Inc. - Company Long-Term Debts|Company Long-Term Liabilities Korro Bio Inc. KRRO|EDIT (Editas Medicine) - Company Long-Term Debts|SLN: Long-Term Debt|proqr.com - Company Long-Term Debt|Long-Term Debt Volume Codexis|SGMO - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Nautilus Biotechnology Inc|MGX (Metagenomi) - Company Long-Term Debts|Long-Term Debt Volume DTIL (Precision BioSciences Inc.)|GBIO - Company Long-Term Debt|Company Long-Term Indebtedness Boundless Bio Inc BOLD|XCUR: Company Long-Term Debts|Imunon, Inc. (IMNN) - Company Long-Term Liabilities|phiopharma.com - Company Long-Term Liabilities|MBIO (Mustang Bio) - Long-Term Debt Volume|RNAZ: Company Long-Term Debt|Long-Term Debt Volume BNGO|Company Long-Term Debt Applied DNA Sciences (APDN)|Company Long-Term Debt bluebirdbio.com (BLUE)|IPA - Company Long-Term Debts|Company Long-Term Indebtedness Omega Therapeutics Inc OMGA|OMIC - Company Long-Term Debts|RGLS - Company Long-Term Debt|Company Long-Term Debts Syros Pharmaceuticals|TBIO (telesisbio.com) - Company Long-Term Indebtedness|Company Long-Term Debt TRACON Pharmaceuticals, Inc. (TCON)|Company Long-Term Indebtedness Unity Biotechnology Inc.